Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Immunologic Features in Coronavirus Disease 2019: Functional Exhaustion of T Cells and Cytokine Storm Publisher Pubmed



Mahmoudi S1 ; Rezaei M2 ; Mansouri N3, 4 ; Marjani M5 ; Mansouri D4, 5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Virology Research Center, National Research Institute of Tuberculosis and Lung diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Division of Pulmonary Medicine, Department of Medicine, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland
  4. 4. Department of Clinical Immunology and Infectious Diseases, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Journal of Clinical Immunology Published:2020


Abstract

[No abstract available]
Related Docs
View other Related Docs
1. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
2. Corona Virus Disease 2019 (Covid-19) As a System-Level Infectious Disease With Distinct Sex Disparities, Frontiers in Immunology (2021)
3. Risk Factors for Adverse Outcomes of Covid-19 Patients: Possible Basis for Diverse Responses to the Novel Coronavirus Sars-Cov-2, Life Sciences (2021)
4. Mesenchymal Stem Cell Therapies for Covid-19: Current Status and Mechanism of Action, Life Sciences (2020)
5. Association Between Serum Inflammatory Parameters and the Disease Severity in Covid-19 Patients, Journal of Clinical Laboratory Analysis (2022)
6. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
7. Immunosenescence and Inflamm-Ageing in Covid-19, Ageing Research Reviews (2023)
8. Immune-Based Therapy for Covid-19, Advances in Experimental Medicine and Biology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (15)
Abdolrahman Rostamian (2)
Other Related Docs
9. Dysregulation of the Immune Response in Coronavirus Disease 2019, Cell Biology International (2021)
10. Natural Killer Cells in Covid-19: From Infection, to Vaccination and Therapy, Future Virology (2023)
11. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
12. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)
13. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
14. Th17 and Treg Cells Function in Sars-Cov2 Patients Compared With Healthy Controls, Journal of Cellular Physiology (2021)
15. Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials, International Immunopharmacology (2022)
16. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
17. The Impact of Covid-19 on Diagnostic Biomarkers in Neuropsychiatric and Neuroimmunological Diseases: A Review, Reviews in the Neurosciences (2022)
18. Auxiliary Role of Mesenchymal Stem Cells As Regenerative Medicine Soldiers to Attenuate Inflammatory Processes of Severe Acute Respiratory Infections Caused by Covid-19, Cell and Tissue Banking (2020)
19. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
20. Exploring the Causes of Mild Covid-19 Involvement in Pediatric Patients, New Microbes and New Infections (2020)
21. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
22. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
23. Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami, Inflammopharmacology (2023)
24. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
25. Tocilizumab in Icu-Admitted Covid-19 Patients: A Retrospective Study, Medical Journal of the Islamic Republic of Iran (2023)
26. Multi-Facets of Neutrophil Extracellular Trap in Infectious Diseases: Moving Beyond Immunity, Microbial Pathogenesis (2021)
27. Dynamic Changes of Lymphocyte Subsets in the Course of Covid-19, International Archives of Allergy and Immunology (2021)
28. Biomarker Based Biosensors: An Opportunity for Diagnosis of Covid-19, Reviews in Medical Virology (2022)
29. The Role of Bacterial and Fungal Human Respiratory Microbiota in Covid-19 Patients, BioMed Research International (2021)
30. The Emerging Role of Micrornas in the Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Infection, International Immunopharmacology (2021)
31. A Systematic Review and Meta-Analysis on the Association Between Lymphocyte Subsets and the Severity of Covid-19, Immunopathologia Persa (2022)
32. Novel Therapeutic Approaches for Treatment of Covid-19, Journal of Molecular Medicine (2020)
33. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
34. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
35. Immunophenotyping Characteristics of Covid-19 Patients: Peripheral Blood Cd8+ Hla-Dr+ T Cells As a Biomarker for Mortality Outcome, Journal of Medical Virology (2023)
36. A Pharmacology-Based Comprehensive Review on Medicinal Plants and Phytoactive Constituents Possibly Effective in the Management of Covid-19, Phytotherapy Research (2021)
37. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
38. Differential Antibody Response to Sars-Cov-2 Antigens in Recovered and Deceased Iranian Covid-19 Patients, Viral Immunology (2021)
39. Can Anti-Parasitic Drugs Help Control Covid-19?, Future Virology (2022)
40. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)
41. Intracranial Aneurysm Rupture After Sars-Cov2 Infection: Case Report and Review of Literature, Pathogens (2022)
42. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
43. Neutrophil to Lymphocyte Ratio and C-Reactive Protein Level As Prognostic Markers in Mild Versus Severe Covid-19 Patients, Gastroenterology and Hepatology from Bed to Bench (2020)
44. Cancer Care Management During the Covid-19 Pandemic, Risk Management and Healthcare Policy (2020)
45. Post-Exposure Prophylaxis for Covid-19: A Systematic Review, Infectious Disorders - Drug Targets (2023)
46. Intravenous Methylprednisolone Pulse As a Treatment for Hospitalised Severe Covid-19 Patients: Results From a Randomised Controlled Clinical Trial, European Respiratory Journal (2020)
47. Nanocurcumin Improves Treg Cell Responses in Patients With Mild and Severe Sars-Cov2, Life Sciences (2021)
48. A Narrative Literature Review on Traditional Medicine Options for Treatment of Corona Virus Disease 2019 (Covid-19), Complementary Therapies in Clinical Practice (2020)
49. Covid-19 Immunotherapy: Treatment Based on the Immune Cell-Mediated Approaches, International Immunopharmacology (2022)
50. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)